The influence of seropositivity for antinuclear antibodies (ANA) on clinical manifestation and response to antiviral therapy for chronic hepatitis C patients
碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 95 === Background: Positive serum antinuclear antibody (ANA) emerges in some proportion of patients with chronic hepatitis C virus (HCV) infection. This study aimed to evaluate the prevalence of ANA in chronic hepatitis C (CHC) patients and to elucidate its clinical im...
Main Authors: | Ming-Yen Hsieh, 謝明彥 |
---|---|
Other Authors: | Wen-Yu Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/04286918511532341673 |
Similar Items
-
Can Antinuclear Antibodies (ANA) be Monoclonal?
by: Laura Biederman, et al.
Published: (2021-01-01) -
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
by: Ming-Yen Hsieh, et al.
Published: (2012-02-01) -
Antinuclear Antibody-Positive Ticlopidine-Induced Hepatitis
by: Sander Jo Veldhuyzen van Zanten, et al.
Published: (1996-01-01) -
A study of antinuclear antibody (ANA)-binding in Lewis rat kidney injected with human serum containing ANA
by: Alhammad, Saad A.
Published: (2013) -
Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)
by: Catalina MD, et al.
Published: (2011-09-01)